Brands
Ronojit Biswas to take charge as GSK Pharma CFO
Juby Chandy exits for Apac finance role; shares slip 0.97 per cent
MUMBAI: GlaxoSmithKline Pharmaceuticals Limited on Monday named Ronojit Biswas as whole-time director and chief financial officer for a three-year term starting 1 April, 2026, signalling a steady internal succession at the drugmaker’s India arm.
Biswas will replace Juby Chandy, who steps down as whole-time director and CFO on 11 March, 2026, after being elevated to lead Apac finance within the wider GSK Group.
A company lifer, Biswas joined GSK in India in 1999 as a management trainee and has since built a 25-year career across India, Vietnam, Singapore, Brazil and the UK. Most recently, he served as senior finance director – global product strategy, based in Singapore.
He has previously held CFO roles in Brazil and Vietnam and was regional controller for GSK’s international region, overseeing financial reporting, performance management and internal controls: a portfolio that sharpened his exposure to global compliance and capital discipline.
Biswas holds a postgraduate degree in management (finance) from Management Development Institute, Gurugram, and a bachelor of commerce (honours) from St. Xavier’s College, Kolkata.
Shares of the company were trading at Rs 2,545.00, down Rs 25.00, or 0.97 per cent, at 12:40 pm, reflecting a muted market response to the boardroom reshuffle.
